ETPharma Latest news
Cipla recalls generic drug in US due to broken tablets | Pfizer names Chris Boshoff as R&D chief | ETPharma Tech Innovate Conclave 2024 today
Unsubscribe   |   Report this Email
ETPharma Newsletter | Friday, November 22, 2024

Daily Newsletter
Top Stories
Cipla recalls over 1.8k boxes of generic drug in US due to broken tablets
Pfizer names oncology head Chris Boshoff as R&D chief
ETPharma Tech Innovate Conclave 2024: Exploring Innovations and Advancements in Pharma-Tech
Pharma Industry
Medical supply firm Medline aims to raise over $5 billion in 2025 IPO, sources say
McKinsey nears deferred prosecution pact in US opioid probe, sources say
Sage to abandon development of neurological disorder drug after multiple failures
Wall Street awaits Amgen weight-loss drug data expected to move shares
Drug Approvals & Logistics
Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment
Finance Performance
Novartis raises sales guidance until 2028
Mergers & Acquisitions
360 ONE Asset acquires stake in OneSource Specialty Pharma
Research & Development
Sage Therapeutics scraps development of rare disease drug after it fails mid-stage study
Follow Us on
Copyright © 2024 ETPharma, All rights reserved.
You are receiving this email because you signed up at etpharma.com
Our mailing address is: ETPharma.com (Times Center), FC6, Sector 16 A, Film City, Noida - 201301 Uttar Pradesh, India
Add newsletter@etpharma.com to your address book   |   Our archives are at ETPharma
Unsubscribe   |   Report this Email
Relay Logo

Forwarded to: wystarczy@pxdmail.net.
Stop email forwarding and manage settings for all aliases here.
Sender: newsletter@etpharma.com
This banner is only visible to you. You can turn if off in a Settings.

Options